NCT04964934 2026-04-21
SERENA-6
AstraZeneca
Phase 3 Active not recruiting
AstraZeneca
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Institute of Cancer Research, United Kingdom
Eli Lilly and Company
UNICANCER
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company